Putting Patients First Blog

JULY 2, 2024

1 And we appreciated CMS’ thorough responses to comments for IPAY 2026 and hope the Agency will replicate this for this comment opportunity. These elements were previously highlighted in our comments in response to the IPAY 2026 guidance, and we continue to stress their importance for the 2027 draft guidance.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing Labelling HIPAA 52

Putting Patients First Blog

JANUARY 27, 2025

Timely implementation is particularly critical for beneficiaries requiring immediate mental health or substance use treatment, where delays can lead to worsening health outcomes, increased hospitalization rates, and preventable mortality. link] duals-rfi/.

Insurance Coverage and Processing 40

Insurance Coverage and Processing Biosimilars Communication Department of Veterans Affairs 40

Pharmaceutical Technology

AUGUST 12, 2022

The Act authorizes the appropriation of $100,000,000 per fiscal year from 2022 to 2026. Dr Merit Cudkowicz, Director, Amyotrophic Lateral Sclerosis Clinic, Massachusetts General Hospital. The latest action plan was made in accordance with President Biden’s law, ‘Accelerating Access to Critical Therapies for ALS Act’ from December 2021.

Hospitals 98

Hospitals 98

Express Pharma

NOVEMBER 24, 2023

This provides an opportunity to directly engage with high-ranking pharma executives, buyers, procurement managers, contract manufacturers, hospital administrators, as well as representatives from national and state regulatory boards and policymakers.

Packaging 105

Packaging Vaccines Pharmaceutical Manufacturing Hospitals 105

pharmaphorum

JANUARY 29, 2023

While global health spending per capita was about US$1,100 in 2018, this is forecast to rise to US$1,700 by 2026, outpacing GDP growth over the same period. For instance, infrastructure funds have started to acquire nursing homes, hospitals, and laboratories under their social infrastructure investment strategies.

Nursing Homes 98

Nursing Homes Hospitals Vaccines 98

Pharmaceutical Technology

MARCH 7, 2023

An ongoing four-year study at Brigham and Women’s Hospital, is now exploring how the allopregnanolone affects behaviour and neurobiology that may underlie perimenopausal depression. “We are doing better with postpartum depression than perimenopausal women,” says Santoro.

Labelling 52

Labelling Hospitals 52

Express Pharma

JANUARY 12, 2024

. – Considering that the government promotes companies to “Make in India”, we request that the time limit for commencing manufacturing or production be further extended to 31 March 2026. Therefore, the sunset period should be extended for borrowings in foreign currency up to 31 March 2026; this would support the vision of “Make in India”.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies Health Insurance Companies 52

Viseven

SEPTEMBER 18, 2024

By the end of 2026, the company will be able to analyze two million genomes. Many are still designed with life sciences companies in mind, requiring patients to make frequent hospital visits without compensation for their time or effort. Isn’t scalability one of the most important goals each drug manufacturer is striving for?

Communication 52

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

Putting Patients First Blog

MARCH 4, 2024

Star Ratings Changes for 2025 and Proposed Changes for 2026 The NHC acknowledges CMS’ ongoing efforts to refine the Part C and D Star Ratings for 2025, aimed at enhancing the system’s accuracy and utility in assessing the quality of MA and PDPs. CMS proposes Medicare Advantage rate cut. Retrieved from https:/ /www.ajmc.co Mavondo, F.,

Insurance Coverage and Processing 40

Insurance Coverage and Processing Communication Hospitals 40

Putting Patients First Blog

NOVEMBER 12, 2024

We appreciate many of the proposed changes in the 2026 NBPP, and our comments are focused on specific provisions where we believe CMS can further strengthen patient-centered health care. Conclusion The NHC appreciates the opportunity to provide input on the 2026 NBPP proposed rule. ” Federal Register 89, no.

Insurance Coverage and Processing 52

Insurance Coverage and Processing HIV Treatment and Prevention Agents Communication Hospitals 52

Pharmaceutical Technology

JANUARY 16, 2023

Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines.

Drug Pricing 64

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 64

Putting Patients First Blog

FEBRUARY 11, 2025

Overarching Comments The NHC acknowledges CMS efforts to implement meaningful policy updates in CY 2026 to advance equity, affordability, and access to high-value care for Medicare beneficiaries. This approach reflects a balance between implementing necessary updates and avoiding immediate, widespread disruptions.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Communication Documentation Hospitals 52

Pharmaceutical Technology

JANUARY 16, 2023

Negotiated prices will not apply until 2026, but the selected medicines for Medicare price negotiations will be unveiled in September 2023. The legislation contains several provisions to lower prescription drug costs, including allowing Medicare to negotiate the cost of selected medicines.

Drug Pricing 52

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 52

STAT

MARCH 24, 2025

The dawn of a new risk adjustment era Within the next two weeks, the Trump administration will roll out the final Medicare Advantage policies and payments rates for 2026. You know what to do: Send her all of your tips, gossip, and random musings at tara.bannow@statnews.com.

Drug Development 179

Drug Development Hospitals 179